Physician profile
Brett Becker
NPI 1730271545
$5,923.64
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.27 · 2020: $174 · 2021: $419 · 2022: $662 · 2023: $189 · 2024: $4,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,440 · Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,440.00 |
| Food and Beverage | $188.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,440.00 | 2024 | |
| Stryker Corporation | $516.10 | 2021-2023 | Actishield |
| Kerecis Limited | $201.01 | 2020-2022 | |
| Abbott Laboratories | $192.03 | 2022 | |
| Organogenesis INC. | $146.17 | 2020-2023 | Puraply |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Ibsa Pharma INC. | $74.15 | 2020-2021 | |
| Acera Surgical, INC. | $73.78 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $48.94 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $39.27 | 2019 | |
| Medela LLC | $24.89 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $19.92 | 2021 | |
| Abbvie INC. | $13.11 | 2022 | |
| Melinta Therapeutics, LLC | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.